A trend toward a reduction in cell viability and wound healing capacity was observed also when AT2R agonist was administered to TNF-α-treated RA-FLS, though these results did not reach statistical significance (Fig. 6a,b ).
← all excerpts
Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium.
1
—
—